Similar articles for PMID: 3006058

Year	Number of Results
1982	2
1983	3
1984	4
1985	4
1986	10
1987	11
1988	6
1989	11
1990	9
1991	7
1992	3
1993	4
1994	2
1995	2
1996	1
1998	2
2001	1
2003	1
2024	0

1

Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells.

Sahyoun N, Wolf M, Besterman J, Hsieh T, Sander M, LeVine H 3rd, Chang KJ, Cuatrecasas P. Sahyoun N, et al. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1603-7. doi: 10.1073/pnas.83.6.1603. Proc Natl Acad Sci U S A. 1986. PMID: 3006058 Free PMC article.

2

Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.

Zwelling LA, Hinds M, Chan D, Altschuler E, Mayes J, Zipf TF. Zwelling LA, et al. Cancer Res. 1990 Nov 15;50(22):7116-22. Cancer Res. 1990. PMID: 2171756

3

The interaction between nuclear topoisomerase II activity from human leukemia cells, exogenous DNA, and 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) or 4-(4,6-O-ethylidene-beta-D-glucopyranoside) (VP-16) indicates the sensitivity of the cells to the drugs.

Estey EH, Silberman L, Beran M, Andersson BS, Zwelling LA. Estey EH, et al. Biochem Biophys Res Commun. 1987 Apr 29;144(2):787-93. doi: 10.1016/s0006-291x(87)80033-5. Biochem Biophys Res Commun. 1987. PMID: 3034264

4

Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.

Zwelling LA, Chan D, Hinds M, Mayes J, Silberman LE, Blick M. Zwelling LA, et al. Cancer Res. 1988 Dec 1;48(23):6625-33. Cancer Res. 1988. PMID: 2846155

5

Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.

Constantinou A, Henning-Chubb C, Huberman E. Constantinou A, et al. Cancer Res. 1989 Mar 1;49(5):1110-7. Cancer Res. 1989. PMID: 2537141

6

Purification and characterization of type II DNA topoisomerase from mouse FM3A cells: phosphorylation of topoisomerase II and modification of its activity.

Saijo M, Enomoto T, Hanaoka F, Ui M. Saijo M, et al. Biochemistry. 1990 Jan 16;29(2):583-90. doi: 10.1021/bi00454a036. Biochemistry. 1990. PMID: 2154252

7

The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA).

Bakic M, Beran M, Andersson BS, Silberman L, Estey E, Zwelling LA. Bakic M, et al. Biochem Biophys Res Commun. 1986 Jan 29;134(2):638-45. doi: 10.1016/s0006-291x(86)80467-3. Biochem Biophys Res Commun. 1986. PMID: 3004458

8

Stabilization of the topoisomerase II-DNA cleavage complex by antineoplastic drugs: inhibition of enzyme-mediated DNA religation by 4'-(9-acridinylamino)methanesulfon-m-anisidide.

Robinson MJ, Osheroff N. Robinson MJ, et al. Biochemistry. 1990 Mar 13;29(10):2511-5. doi: 10.1021/bi00462a012. Biochemistry. 1990. PMID: 2159323

9

Phosphorylation of DNA topoisomerase II in vivo and in total homogenates of Drosophila Kc cells. The role of casein kinase II.

Ackerman P, Glover CV, Osheroff N. Ackerman P, et al. J Biol Chem. 1988 Sep 5;263(25):12653-60. J Biol Chem. 1988. PMID: 2842338 Free article.

10

Rapid increase in the activity of DNA topoisomerase I, but not topoisomerase II, in HL-60 promyelocytic leukemia cells treated with a phorbol diester.

Gorsky LD, Cross SM, Morin MJ. Gorsky LD, et al. Cancer Commun. 1989;1(2):83-92. doi: 10.3727/095535489820875381. Cancer Commun. 1989. PMID: 2561736

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year